NYSE$NHI

National Health Investors Inc · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

Net income and AFFO increased for the fourth quarter of 2019.

National Health Investors reported a net income of $0.95 per diluted common share for Q4 2019, a 9.2% increase year-over-year, and AFFO of $1.30 per diluted common share, a 2.4% increase year-over-year.

  • GAAP net income attributable to common stockholders of $0.95 for the fourth quarter.
  • AFFO of $1.30 for the fourth quarter.
  • Portfolio lease coverage remains strong at 1.66x.
  • Q4 2019 fixed charge coverage remains conservative at 5.7x.

Headline financials

Total Revenue

$82.2M

Previous: $74M+11.1%
EPS (adj)

$1.41

Previous: $1.35+4.4%
Capital Expenditures

$237M

Previous: $148M+60.6%
Free Cash Flow

-$181M

Previous: -$95.8M-89.0%
Net Income

$42M

Previous: $37.1M+13.4%
Operating Income

$42.9M

No prior period
Gross Profit

$80.6M

Previous: $73.7M+9.4%
Cash & Equivalents

$5.22M

Previous: $4.66M+11.9%
Total Assets

$2.96B

Previous: $2.75B+7.5%

Revenue & EPS history

NHI · Revenue · Quarterly

$82.2M

Q4 2019+11.1%vs Q4 2018
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

NHI · $82.2M total across 2 segments · Q4 2019

  • Rental income
    $75.4M
  • Interest income and other
    $6.79M

Forward guidance

The Company currently expects net income to be in the range of $4.33 to $4.47 per diluted common share, Normalized FFO for 2020 to be in the range of $5.67 to $5.71 per diluted common share and Normalized AFFO to be in the range of $5.31 to $5.35 per diluted common share.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+1.3%

Avg return

30 days after

59%

40 / 68 earnings

Positive

+14.9%

Q3 2020

Best reaction

-7.9%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.9%-9.4%
Q4 2025-4.2%-3.2%-6.3%
Q3 2025+1.8%+1.1%+4.1%
Q1 2025+0.5%+1.0%-6.2%
Q4 2024-0.2%+2.9%+4.8%
Q3 2024+1.1%+7.0%-0.4%
Q2 2024+3.0%+3.2%+13.8%
Q1 2024+1.4%+0.9%+2.8%
Q4 2023+6.6%+8.4%+16.5%
Q3 2023+0.5%-0.7%+7.8%
Q2 2023-7.5%-6.7%-9.4%
Q1 2023+7.6%+8.3%+8.0%
Q4 2022-7.9%-6.5%-17.5%
Q3 2022-1.4%+3.4%+2.1%
Q2 2022+2.6%+4.9%+4.5%
Q1 2022-3.4%+1.4%+12.8%
Q4 2021-3.2%-2.0%+6.4%
Q3 2021+1.4%+1.8%+1.4%
Q2 2021-6.2%-5.5%-9.7%
Q1 2021-3.1%-4.9%-5.6%
Q4 2020-0.6%+0.1%+7.5%
Q3 2020+14.9%+18.0%+20.7%
Q2 2020+0.1%-2.8%-1.0%
Q1 2020-4.2%-11.3%+19.2%
Q4 2019+1.4%+1.8%-57.5%
Q3 2019-2.0%-2.0%+1.0%
Q2 2019+2.1%+2.0%+3.9%
Q1 2019-1.2%+0.8%+3.4%
Q4 2018-6.9%-4.0%-5.7%
Q3 2018+1.6%+2.4%+8.0%
Q2 2018+1.0%+0.1%+3.1%
Q1 2018+1.9%+1.7%+6.7%
Q4 2017+0.0%+0.8%+7.5%
Q3 2017-2.9%-1.5%-0.6%
Q2 2017+1.0%+2.8%+6.7%
Q1 2017+2.5%+4.4%+5.1%
Q4 2016+0.7%+1.1%-3.9%
Q3 2016-0.3%-5.5%+1.1%
Q2 2016+0.6%+2.0%+3.4%
Q1 2016+1.9%
Q4 2015+3.8%
Q3 2015-0.1%
Q2 2015-1.9%
Q1 2015+1.5%
Q4 2014+0.4%
Q3 2014-0.7%
Q2 2014+2.6%
Q1 2014+1.5%
Q4 2013-1.0%
Q3 2013-0.7%
Q2 2013-0.0%
Q1 2013+3.3%
Q4 2012-1.1%
Q3 2012+1.3%
Q2 2012-2.7%
Q1 2012+1.2%
Q4 2011-2.4%
Q3 2011+0.8%
Q2 2011-5.4%
Q1 2010-2.5%
Q1 2011+0.1%
Q4 2008+0.2%
Q4 2010+0.2%
Q3 2010+1.6%
Q3 2009+1.6%
Q2 2010+0.9%
Q2 2009+0.9%
Q4 2009+0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro